We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+9.41%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$36.7B
AUM Growth
+$3.15B
(+9.4%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
5.15%
Holding
3,891
New
644
Increased
1,079
Reduced
1,381
Closed
771
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$159M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$156M |
| 3 |
Intel
INTC
|
+$140M |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$125M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$168M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$160M |
| 3 |
Meta Platforms (Facebook)
META
|
+$147M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$142M |
| 5 |
Baidu
BIDU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.13% |
| 2 | Consumer Discretionary | 12.6% |
| 3 | Industrials | 10.86% |
| 4 | Healthcare | 10.49% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
CALL
CVS Health
CVS
$119B
| $1.04M | ﹤0.01% |
13,200
-9,300
| -41% | -$665K |
|
1952
LendingTree
TREE
$436M
| $1.04M | ﹤0.01% |
4,517
+440
| +11% | +$105K |
|
|
CBD
1953
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $1.04M | ﹤0.01% |
+48,346
| New | +$984K |
|
|
NWY
1954
DELISTED
New York & Co Inc
NWY
| $1.03M | ﹤0.01% |
268,168
+229,068
| +586% | +$1.08M |
|
1955
MiMedx Group
MDXG
$631M
| $1.03M | ﹤0.01% |
167,143
+43,334
| +35% | +$196K |
|
1956
PUT
L3Harris
LHX
$48.9B
| $1.03M | ﹤0.01% |
+6,100
| New | +$971K |
|
1957
MYR Group
MYRG
$4.69B
| $1.03M | ﹤0.01% |
31,616
-16,870
| -35% | -$594K |
|
|
SLCA
1958
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.03M | ﹤0.01% |
54,800
-3,800
| -6% | -$88.2K |
|
|
ELGX
1959
DELISTED
Endologix Inc
ELGX
| $1.03M | ﹤0.01% |
53,976
+19,165
| +55% | +$684K |
|
|
NBL
1960
PUT
DELISTED
Noble Energy, Inc.
NBL
| $1.03M | ﹤0.01% |
+33,000
| New | +$1.06M |
|
1961
PUT
Nucor
NUE
$55.8B
| $1.03M | ﹤0.01% |
16,200
-25,500
| -61% | -$1.63M |
|
1962
Hawkins
HWKN
$2.46B
| $1.03M | ﹤0.01% |
49,560
-29,324
| -37% | -$579K |
|
1963
New Mountain Finance
NMFC
$717M
| $1.03M | ﹤0.01% |
76,062
-65,355
| -46% | -$905K |
|
1964
CALL
Bristol-Myers Squibb
BMY
$138B
| $1.02M | ﹤0.01% |
16,500
-127,600
| -89% | -$7.57M |
|
|
GHDX
1965
DELISTED
Genomic Health, Inc.
GHDX
| $1.02M | ﹤0.01% |
14,588
-55,726
| -79% | -$3.26M |
|
|
BID
1966
DELISTED
Sotheby's
BID
| $1.02M | ﹤0.01% |
20,819
-1,304
| -6% | -$65.9K |
|
1967
CALL
PACCAR
PCAR
$68.2B
| $1.02M | ﹤0.01% |
22,500
-7,800
| -26% | -$344K |
|
1968
FirstService
FSV
$6.27B
| $1.02M | ﹤0.01% |
12,089
-6,203
| -34% | -$515K |
|
|
WBA
1969
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $1.02M | ﹤0.01% |
14,000
-92,400
| -87% | -$6.27M |
|
|
VRAY
1970
DELISTED
ViewRay, Inc.
VRAY
| $1.02M | ﹤0.01% |
+109,071
| New | +$1.07M |
|
1971
PUT
Estee Lauder
EL
$37.5B
| $1.02M | ﹤0.01% |
+7,000
| New | +$972K |
|
|
PDLI
1972
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.02M | ﹤0.01% |
386,828
+212,225
| +122% | +$521K |
|
1973
ICF International
ICFI
$1.58B
| $1.02M | ﹤0.01% |
13,471
-28,029
| -68% | -$2.15M |
|
1974
J. Jill
JILL
$292M
| $1.01M | ﹤0.01% |
39,069
+25,265
| +183% | +$786K |
|
1975
Ingevity
NGVT
$2.37B
| $1.01M | ﹤0.01% |
9,946
-1,332
| -12% | -$129K |
|
Similar funds
John Overdeck's Q3 2018 Portfolio in Review
As of Q3 2018, John Overdeck held 3,891 positions worth $36.7B, up 9.4% from $33.5B the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
John Overdeck's Q3 2018 filing shows 644 new, 1,079 increased, 1,381 reduced and 771 closed positions. Its largest new stake was Royal Caribbean: 1,011,770 shares worth $131M. The largest sale was Burlington, an estimated $168M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.
- John Overdeck's largest Q3 2018 buy was Royal Caribbean: 1,011,770 shares worth $131M.
- John Overdeck added most to Boeing in Q3 2018, an estimated $159M increase.
- John Overdeck's biggest Q3 2018 reduction was Burlington, cutting an estimated $168M.
- John Overdeck fully exited Align Technology in Q3 2018, selling an estimated $116M.
- John Overdeck's ten largest holdings make up 5.1% of its $36.7B portfolio in Q3 2018.
- John Overdeck opened 644 new positions and closed 771 in Q3 2018.
- John Overdeck's portfolio value rose 9.4% quarter-over-quarter to $36.7B.
Based on Two Sigma Investments's 13F filing for Q3 2018, filed 14 Nov 2018.